Results 121 to 130 of about 21,166 (196)

Transarterial chemoembolization combined with immunotherapy and targeted therapy as first-line treatment for unresectable and non-metastatic hepatocellular carcinoma: a meta-analysis of phase III trials. [PDF]

Ther Adv Gastroenterol
Wang L, Luo B, Zhao M, Shen J.
europepmc   +1 more source

The Clinical Impact of Cardiovascular Thrombosis on Overall Survival in Patients With Hepatocellular Carcinoma After Transarterial Chemoembolization. [PDF]

Cancer Med
Fujita K, Takuma K, Nakahara M, Suto H, Morishita A, Himoto T, Okano K, Kobara H.   +7 more
europepmc   +1 more source

Therapeutic approaches in intermediate-stage hepatocellular carcinoma (HCC): a novel insight of adjuvant transarterial chemoembolization (TACE)

Chinese Clinical Oncology, 2023
Paula, Fernández-Palanca, José L, Mauriz   +1 more
openaire   +2 more sources

Long-Term Outcomes of Transarterial Chemoembolization for Intrahepatic Cholangiocarcinoma: Overall Survival and Tumor Response. [PDF]

Cureus
Vogl TJ, Hillebrand A, Bielfeldt J, Finkelmeier F, Pession U, Adwan H.   +5 more
europepmc   +1 more source

Combining Transarterial Chemoembolization with Sorafenib Improves Survival in Selected Patients with Hepatocellular Carcinoma and Extrahepatic Spread: A Multicenter Real-World Study. [PDF]

J Hepatocell Carcinoma
Yuan Y, Qiao Y, Zhu Y, Guo P, Gou J, Liu K, Wang L, Zhao S, Zhang Y, Liu Y, Wang E, Liu L.   +11 more
europepmc   +1 more source

Diagnosis and Treatment Report of a Case of Small Hepatocellular Carcinoma With Left Adrenal Metastasis and Hemorrhage in an Elderly Male Hepatitis B Virus Carrier. [PDF]

Clin Case Rep
Zhou G, Wu F, Feng T, Lin T.
europepmc   +1 more source

Extent of Embolization as an Independent Prognostic Factor in Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma. [PDF]

J Hepatocell Carcinoma
Okumura K, Ogi T, Matsumoto J, Asato N, Kitao A, Kobayashi S, Kozaka K.   +6 more
europepmc   +1 more source

Efficacy and safety of tyrosine kinase inhibitors combined with sintilimab and transarterial chemoembolization in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma: a pooled analysis. [PDF]

J Gastrointest Oncol
Lu GL, Tu JM, Hussainzai A, Tong F, Jiang R.   +4 more
europepmc   +1 more source

Efficacy and safety of DEB-TACE combined with HAIC and donafenib in the treatment of unresectable hepatocellular carcinoma: a dual-center retrospective study. [PDF]

BMC Cancer
Zhang X, Fang X, Wang R, Xiong B, Long J, Guo Q, Chu M, Luo W, Shi S.   +8 more
europepmc   +1 more source

Efficacy and safety of sintilimab plus a bevacizumab biosimilar combined with transarterial chemoembolization for advanced hepatocellular carcinoma. [PDF]

Medicine (Baltimore)
Yang J, Xu Q, Wu S.
europepmc   +1 more source